Search details
1.
Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
Invest New Drugs
; 34(1): 41-8, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26572909
2.
Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.
Eur Radiol
; 26(2): 601-9, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26060065
3.
Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer.
Cancer Chemother Pharmacol
; 90(2): 149-160, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35867144
4.
Design and Mechanism of Action of a New Prototype of Combi-Molecule "Programed" to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment.
Pharmaceuticals (Basel)
; 14(2)2021 Feb 16.
Article
in English
| MEDLINE | ID: mdl-33669415
5.
Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non-Small Cell Lung Carcinoma.
CPT Pharmacometrics Syst Pharmacol
; 7(1): 42-50, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29218795
6.
CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.
Blood Adv
; 2(5): 462-469, 2018 03 13.
Article
in English
| MEDLINE | ID: mdl-29490977
7.
Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis.
Oncotarget
; 8(14): 23087-23098, 2017 Apr 04.
Article
in English
| MEDLINE | ID: mdl-28416742
8.
Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients.
Oncotarget
; 8(29): 47161-47166, 2017 Jul 18.
Article
in English
| MEDLINE | ID: mdl-28525370
9.
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.
Sci Rep
; 7(1): 2714, 2017 06 02.
Article
in English
| MEDLINE | ID: mdl-28578404
10.
Pharmacokinetic interaction between pazopanib and cisplatin regimen.
Cancer Chemother Pharmacol
; 77(2): 385-92, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26779916
11.
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study.
Oncol Ther
; 4(2): 211-223, 2016.
Article
in English
| MEDLINE | ID: mdl-28261651
12.
Pharmacokinetics of pazopanib administered in combination with bevacizumab.
Cancer Chemother Pharmacol
; 73(6): 1189-96, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24705975
Results
1 -
12
de 12
1
Next >
>>